Berichrom PAI (Plasmin activator inhibitors). An in vitro diagnostic medical device (IVD) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Siemens Ltd Diagnostics Division 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2013-RN-00447-1
  • 사례 위험등급
    Class III
  • 사례 시작날짜
    2013-05-16
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    The incorrect table of assigned values (tav) was provided with the product. the use of the incorrect values for standard 2 will result in slightly increase calibration curves, potentially resulting in decreased values for patient samples. the degree of deviation is less than 10 percent.
  • 조치
    Customers who use the manual method to carry out the test are requested to use the assigned values provided in the recall correspondence. The values provided on the Lot Data CD for use with the BCS/BCS XP systems are correct.

Device

  • 모델명 / 제조번호(시리얼번호)
    Berichrom PAI (Plasmin activator inhibitors). An in vitro diagnostic medical device (IVD)Catalogue number: OWOA15Siemens material number: 10446642Lot number: 541577
  • Manufacturer

Manufacturer